Clinical characteristics and molecular genetic analysis of Korean patients with GNE myopathy

Jae Eun Sim, Hyung Jun Park, Ha Young Shin, Tai Seung Nam, Seung Min Kim, Young Chul Choi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose: Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE) myopathy is an autosomal recessive neuromuscular disorder characterized by early adult-onset weakness of the distal muscles of the lower limbs. The clinical spectrum of GNE myopathy varies, and it is not clear how the same GNE gene mutations can result in different phenotypes. Here, we present clinical, pathological and genetic characteristics of twenty-one Korean patients with GNE myopathy. Materials and Methods: Twenty-one GNE myopathy patients were included in this study, conducted from 2004 to 2011. Based on medical records, patients' gender, onset age, family history, clinical history, serum creatine kinase (CK) level, neurologic examination, findings of muscle biopsy, muscle imaging findings and electrophysiologic features were extensively reviewed. Mutation of the GNE gene (9p13.3) was confirmed by DNA direct sequencing analysis in all patients. Results: The mean onset age was 23.8±8.8 years (mean±SD). Patient serum CK levels were slightly to moderately elevated, ranging from 41 to 2610 IU. Among the patients, twelve patients were female and nine patients were male. Except for eight patients, all of the patients presented initially with only distal muscle weakness in the lower extremities. The most common mutation was V572L, followed by C13S. Conclusion: The clinical manifestations of our patients with GNE mutations varied. Among twenty-one patients, thirteen patients showed the typical GNE myopathy phenotype. There was no relationship between clinical features and site of mutation. Therefore, we suggest that neither homozygous nor compound heterozygous models are correlated with disease phenotype or disease severity.

Original languageEnglish
Pages (from-to)578-582
Number of pages5
JournalYonsei medical journal
Volume54
Issue number3
DOIs
Publication statusPublished - 2013 May 1

Fingerprint

Muscular Diseases
Molecular Biology
Mutation
N-acylmannosamine kinase
Muscle Weakness
Creatine Kinase
Phenotype
Age of Onset
Lower Extremity
Racemases and Epimerases
Muscles
Neurologic Examination
Neurologic Manifestations
Serum
DNA Sequence Analysis
Genes
Medical Records

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Sim, Jae Eun ; Park, Hyung Jun ; Shin, Ha Young ; Nam, Tai Seung ; Kim, Seung Min ; Choi, Young Chul. / Clinical characteristics and molecular genetic analysis of Korean patients with GNE myopathy. In: Yonsei medical journal. 2013 ; Vol. 54, No. 3. pp. 578-582.
@article{ee2de4593f444be391041f20089ff27d,
title = "Clinical characteristics and molecular genetic analysis of Korean patients with GNE myopathy",
abstract = "Purpose: Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE) myopathy is an autosomal recessive neuromuscular disorder characterized by early adult-onset weakness of the distal muscles of the lower limbs. The clinical spectrum of GNE myopathy varies, and it is not clear how the same GNE gene mutations can result in different phenotypes. Here, we present clinical, pathological and genetic characteristics of twenty-one Korean patients with GNE myopathy. Materials and Methods: Twenty-one GNE myopathy patients were included in this study, conducted from 2004 to 2011. Based on medical records, patients' gender, onset age, family history, clinical history, serum creatine kinase (CK) level, neurologic examination, findings of muscle biopsy, muscle imaging findings and electrophysiologic features were extensively reviewed. Mutation of the GNE gene (9p13.3) was confirmed by DNA direct sequencing analysis in all patients. Results: The mean onset age was 23.8±8.8 years (mean±SD). Patient serum CK levels were slightly to moderately elevated, ranging from 41 to 2610 IU. Among the patients, twelve patients were female and nine patients were male. Except for eight patients, all of the patients presented initially with only distal muscle weakness in the lower extremities. The most common mutation was V572L, followed by C13S. Conclusion: The clinical manifestations of our patients with GNE mutations varied. Among twenty-one patients, thirteen patients showed the typical GNE myopathy phenotype. There was no relationship between clinical features and site of mutation. Therefore, we suggest that neither homozygous nor compound heterozygous models are correlated with disease phenotype or disease severity.",
author = "Sim, {Jae Eun} and Park, {Hyung Jun} and Shin, {Ha Young} and Nam, {Tai Seung} and Kim, {Seung Min} and Choi, {Young Chul}",
year = "2013",
month = "5",
day = "1",
doi = "10.3349/ymj.2013.54.3.578",
language = "English",
volume = "54",
pages = "578--582",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "3",

}

Clinical characteristics and molecular genetic analysis of Korean patients with GNE myopathy. / Sim, Jae Eun; Park, Hyung Jun; Shin, Ha Young; Nam, Tai Seung; Kim, Seung Min; Choi, Young Chul.

In: Yonsei medical journal, Vol. 54, No. 3, 01.05.2013, p. 578-582.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical characteristics and molecular genetic analysis of Korean patients with GNE myopathy

AU - Sim, Jae Eun

AU - Park, Hyung Jun

AU - Shin, Ha Young

AU - Nam, Tai Seung

AU - Kim, Seung Min

AU - Choi, Young Chul

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Purpose: Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE) myopathy is an autosomal recessive neuromuscular disorder characterized by early adult-onset weakness of the distal muscles of the lower limbs. The clinical spectrum of GNE myopathy varies, and it is not clear how the same GNE gene mutations can result in different phenotypes. Here, we present clinical, pathological and genetic characteristics of twenty-one Korean patients with GNE myopathy. Materials and Methods: Twenty-one GNE myopathy patients were included in this study, conducted from 2004 to 2011. Based on medical records, patients' gender, onset age, family history, clinical history, serum creatine kinase (CK) level, neurologic examination, findings of muscle biopsy, muscle imaging findings and electrophysiologic features were extensively reviewed. Mutation of the GNE gene (9p13.3) was confirmed by DNA direct sequencing analysis in all patients. Results: The mean onset age was 23.8±8.8 years (mean±SD). Patient serum CK levels were slightly to moderately elevated, ranging from 41 to 2610 IU. Among the patients, twelve patients were female and nine patients were male. Except for eight patients, all of the patients presented initially with only distal muscle weakness in the lower extremities. The most common mutation was V572L, followed by C13S. Conclusion: The clinical manifestations of our patients with GNE mutations varied. Among twenty-one patients, thirteen patients showed the typical GNE myopathy phenotype. There was no relationship between clinical features and site of mutation. Therefore, we suggest that neither homozygous nor compound heterozygous models are correlated with disease phenotype or disease severity.

AB - Purpose: Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE) myopathy is an autosomal recessive neuromuscular disorder characterized by early adult-onset weakness of the distal muscles of the lower limbs. The clinical spectrum of GNE myopathy varies, and it is not clear how the same GNE gene mutations can result in different phenotypes. Here, we present clinical, pathological and genetic characteristics of twenty-one Korean patients with GNE myopathy. Materials and Methods: Twenty-one GNE myopathy patients were included in this study, conducted from 2004 to 2011. Based on medical records, patients' gender, onset age, family history, clinical history, serum creatine kinase (CK) level, neurologic examination, findings of muscle biopsy, muscle imaging findings and electrophysiologic features were extensively reviewed. Mutation of the GNE gene (9p13.3) was confirmed by DNA direct sequencing analysis in all patients. Results: The mean onset age was 23.8±8.8 years (mean±SD). Patient serum CK levels were slightly to moderately elevated, ranging from 41 to 2610 IU. Among the patients, twelve patients were female and nine patients were male. Except for eight patients, all of the patients presented initially with only distal muscle weakness in the lower extremities. The most common mutation was V572L, followed by C13S. Conclusion: The clinical manifestations of our patients with GNE mutations varied. Among twenty-one patients, thirteen patients showed the typical GNE myopathy phenotype. There was no relationship between clinical features and site of mutation. Therefore, we suggest that neither homozygous nor compound heterozygous models are correlated with disease phenotype or disease severity.

UR - http://www.scopus.com/inward/record.url?scp=84875892186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875892186&partnerID=8YFLogxK

U2 - 10.3349/ymj.2013.54.3.578

DO - 10.3349/ymj.2013.54.3.578

M3 - Article

C2 - 23549799

AN - SCOPUS:84875892186

VL - 54

SP - 578

EP - 582

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 3

ER -